These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12891154)

  • 1. Nutritional cofactor treatment in mitochondrial disorders.
    Marriage B; Clandinin MT; Glerum DM
    J Am Diet Assoc; 2003 Aug; 103(8):1029-38. PubMed ID: 12891154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders.
    Marriage BJ; Clandinin MT; Macdonald IM; Glerum DM
    Mol Genet Metab; 2004 Apr; 81(4):263-72. PubMed ID: 15059613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction.
    Orsucci D; Filosto M; Siciliano G; Mancuso M
    Nutr Rev; 2009 Aug; 67(8):427-38. PubMed ID: 19674340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies.
    Tarnopolsky MA
    Adv Drug Deliv Rev; 2008; 60(13-14):1561-7. PubMed ID: 18647623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.
    Geromel V; Darin N; Chrétien D; Bénit P; DeLonlay P; Rötig A; Munnich A; Rustin P
    Mol Genet Metab; 2002; 77(1-2):21-30. PubMed ID: 12359126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapies for mitochondrial diseases and current clinical trials.
    El-Hattab AW; Zarante AM; Almannai M; Scaglia F
    Mol Genet Metab; 2017 Nov; 122(3):1-9. PubMed ID: 28943110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome.
    Dare AJ; Phillips AR; Hickey AJ; Mittal A; Loveday B; Thompson N; Windsor JA
    Free Radic Biol Med; 2009 Dec; 47(11):1517-25. PubMed ID: 19715753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
    Haas RH
    Mitochondrion; 2007 Jun; 7 Suppl():S136-45. PubMed ID: 17485245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional and exercise-based therapies in the treatment of mitochondrial disease.
    Mahoney DJ; Parise G; Tarnopolsky MA
    Curr Opin Clin Nutr Metab Care; 2002 Nov; 5(6):619-29. PubMed ID: 12394637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MITOCHONDRIAL DYSFUNCTION: MODERN ASPECTS OF THERAPY (REVIEW)].
    Arveladze G; Geladze N; Khachapuridze N; Bakhtadze S; Kapanadze N
    Georgian Med News; 2015; (244-245):78-84. PubMed ID: 26177139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease.
    Kasparová S; Sumbalová Z; Bystrický P; Kucharská J; Liptaj T; Mlynárik V; Gvozdjáková A
    Neurochem Int; 2006 Jan; 48(2):93-9. PubMed ID: 16290265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders.
    Rodriguez MC; MacDonald JR; Mahoney DJ; Parise G; Beal MF; Tarnopolsky MA
    Muscle Nerve; 2007 Feb; 35(2):235-42. PubMed ID: 17080429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary intervention and oxidative phosphorylation capacity.
    Morava E; Rodenburg R; van Essen HZ; De Vries M; Smeitink J
    J Inherit Metab Dis; 2006 Aug; 29(4):589. PubMed ID: 16786255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional support in mitochondrial diseases: the state of the art.
    Rinninella E; Pizzoferrato M; Cintoni M; Servidei S; Mele MC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4288-4298. PubMed ID: 30024619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
    Plecitá-Hlavatá L; Jezek J; Jezek P
    Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Coenzyme Q10 supplementation on mitochondrial electron transport chain activity and mitochondrial oxidative stress in Coenzyme Q10 deficient human neuronal cells.
    Duberley KE; Heales SJ; Abramov AY; Chalasani A; Land JM; Rahman S; Hargreaves IP
    Int J Biochem Cell Biol; 2014 May; 50():60-3. PubMed ID: 24534273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coenzyme Q10 in neurodegenerative diseases.
    Shults CW
    Curr Med Chem; 2003 Oct; 10(19):1917-21. PubMed ID: 12871093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Dysfunction in Critical Illness: Implications for Nutritional Therapy.
    McClave SA; Wischmeyer PE; Miller KR; van Zanten ARH
    Curr Nutr Rep; 2019 Dec; 8(4):363-373. PubMed ID: 31713718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria.
    Perumal SS; Shanthi P; Sachdanandam P
    Chem Biol Interact; 2005 Feb; 152(1):49-58. PubMed ID: 15766922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.